Regenxbio (RGNX) Gross Profit Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Gross Profit Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.66% |
| Sep 30, 2025 | -21.70% |
| Jun 30, 2025 | 6.33% |
| Mar 31, 2025 | 42.49% |
| Dec 31, 2024 | 13.30% |
| Sep 30, 2024 | -0.66% |
| Jun 30, 2024 | 13.61% |
| Mar 31, 2024 | 66.87% |
| Dec 31, 2023 | -21.97% |
| Sep 30, 2023 | 28.11% |
| Jun 30, 2023 | -21.91% |
| Mar 31, 2023 | -35.05% |
| Dec 31, 2022 | 62.11% |
| Sep 30, 2022 | 83.04% |
| Jun 30, 2022 | 30.30% |
| Mar 31, 2022 | 77.98% |
| Dec 31, 2021 | 194.38% |
| Sep 30, 2021 | 176.57% |
| Jun 30, 2021 | 39.34% |
| Mar 31, 2021 | 107.71% |